Trending...
- Netvantage SEO Launches Therapist SEO - 184
- Scarecrow Fest offers fall-themed activities at Frankenmuth River Place Shops - 173
- Pear Sperling Eggan & Daniels, P.C. Attorneys Recognized as 2025 Super Lawyers - 172
FAYETTEVILLE, Ark. - Michimich -- Lineus Medical announces publication of the randomized controlled trial performed at Colorado State University Veterinary Teaching Hospital in the Journal of the American Veterinary Medical Association. The canine study had a total of 367 patients and documented the impact that a new class of peripheral IV breakaway devices had on IV complications in hospitalized dogs. The results of the study found that the use of SafeBreak Vascular Vet, Lineus Medical's break-away device, reduced IV complications by 65%.1 Additionally, the results indicated that SafeBreak use may also limit patient discomfort, owner (client) expense, and staff time devoted to managing IV complications.1
SafeBreak® Vascular Vet is a breakaway device that removes harmful forces from peripheral IV lines. The device is installed between the long IV tubing from the pump, and the patient's IV catheter. When harmful forces are applied to the IV line, SafeBreak separates to protect the patient and the IV line. SafeBreak has been proven to reduce IV complications in both small and large animals2. Lineus Medical sponsored the study to document the impact that SafeBreak has on IV complications rates compared to the standard of care. The study demonstrated that there was a statistically significant reduction in overall IV complications when SafeBreak was used. This included reducing IV-line breakage by 92%, dislodgement by 80%, phlebitis by 86%, and occlusion by 100%.1
More on Michimich.com
"Reducing peripheral IV complications is imperative as it ensures that the patient receives all prescribed treatments in a timely manner, but it also may reduce the risk for venous depletion, reduce client costs, and minimize pain for the dog," said Sydney Simpson, co-author of the study.
Dr. Kristin Zersen, principal investigator and senior study author, adds, "This study highlighted a tremendous clinical benefit where the use of SafeBreak Vascular Vet decreased the overall IV complication rate by 65%. With the cost of replacing an IV around $60 compared to the $6.90 cost to replace SafeBreak, this reduction in complications equates to a significant cost savings to the client.1 Just as important, it reduces the need for IV replacement, which can cause pain and anxiety for our patients."
"We were thrilled that the results from this canine study were so significant. In veterinary medicine, the way procedures and supplies are billed to the pet owner is very straight forward compared to a human hospital. This allowed us to clearly show that reducing IV complications with SafeBreak delivers a direct clinical and financial benefit for patients, clients, and care providers," said Spencer Jones, Founder and Chief Technology Officer at Lineus Medical.
More on Michimich.com
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a unique, patented, break-away technology designed to help reduce complications associated with a variety of medical tubing, such as feeding tubes, urinary catheters and other medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Twitter, or Instagram.
MKG 0158 Rev 00
References
1. Simpson, S. E., & Zersen, K. M. (2022). Fewer peripheral intravenous catheter complications in hospitalized dogs when force-activated separation devices are used versus not used in a randomized controlled clinical trial. Journal of the American Veterinary Medical Association, 1–6. https://doi.org/10.2460/javma.22.03.0125
2. University of Tennessee Large Animal Study Data on File
SafeBreak® Vascular Vet is a breakaway device that removes harmful forces from peripheral IV lines. The device is installed between the long IV tubing from the pump, and the patient's IV catheter. When harmful forces are applied to the IV line, SafeBreak separates to protect the patient and the IV line. SafeBreak has been proven to reduce IV complications in both small and large animals2. Lineus Medical sponsored the study to document the impact that SafeBreak has on IV complications rates compared to the standard of care. The study demonstrated that there was a statistically significant reduction in overall IV complications when SafeBreak was used. This included reducing IV-line breakage by 92%, dislodgement by 80%, phlebitis by 86%, and occlusion by 100%.1
More on Michimich.com
- Pastor Reeves Launches Pastor Reeves Studio: Original Christian Artwork Now Available Online
- Michigan Food as Medicine Summit to Bring Together Health, Policy, & Community Leaders Oct 7–8
- Youth Take the Lead: Kopp Foundation for Diabetes Hosts "By Youth, For Youth, With T1D" Gala on October 8 at Blue Bell Country Club
- Green Office Partner Named #1 Best Place to Work in Chicago by Crain's for 2025
- Roofman USA Expands Roofing Services Across Michigan, Adding Key Locations
"Reducing peripheral IV complications is imperative as it ensures that the patient receives all prescribed treatments in a timely manner, but it also may reduce the risk for venous depletion, reduce client costs, and minimize pain for the dog," said Sydney Simpson, co-author of the study.
Dr. Kristin Zersen, principal investigator and senior study author, adds, "This study highlighted a tremendous clinical benefit where the use of SafeBreak Vascular Vet decreased the overall IV complication rate by 65%. With the cost of replacing an IV around $60 compared to the $6.90 cost to replace SafeBreak, this reduction in complications equates to a significant cost savings to the client.1 Just as important, it reduces the need for IV replacement, which can cause pain and anxiety for our patients."
"We were thrilled that the results from this canine study were so significant. In veterinary medicine, the way procedures and supplies are billed to the pet owner is very straight forward compared to a human hospital. This allowed us to clearly show that reducing IV complications with SafeBreak delivers a direct clinical and financial benefit for patients, clients, and care providers," said Spencer Jones, Founder and Chief Technology Officer at Lineus Medical.
More on Michimich.com
- Roofman USA Highlights the Importance of Hiring Specialized Residential Roofers in Ann Arbor
- Wilderness Construction Offers Expert Guidance on Siding Color Selection for Ann Arbor Homeowners
- Japanese Martial Arts Center Promotes Karate as Stress Relief for Ann Arbor Adults
- CCHR, a Mental Health Watchdog Organization, Hosts Weekly Events Educating Citizens on Important Mental Health Issues
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a unique, patented, break-away technology designed to help reduce complications associated with a variety of medical tubing, such as feeding tubes, urinary catheters and other medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Twitter, or Instagram.
MKG 0158 Rev 00
References
1. Simpson, S. E., & Zersen, K. M. (2022). Fewer peripheral intravenous catheter complications in hospitalized dogs when force-activated separation devices are used versus not used in a randomized controlled clinical trial. Journal of the American Veterinary Medical Association, 1–6. https://doi.org/10.2460/javma.22.03.0125
2. University of Tennessee Large Animal Study Data on File
Source: Lineus Medical
Filed Under: Health
0 Comments
Latest on Michimich.com
- Where the Miami Dolphins Stand After Week 1
- Which NFL Teams Can Rebound from Week 1? OddsTrader Breaks Down the Biggest Questions
- Apellix Deploys Breakthrough Spray-Painting Drones into Live Service Limited Beta Program Open for Advanced Contractors
- DivX Unveils New Educational Blog Series to Simplify MKV to MP4 Video Conversion
- CCHR: For Prevention, Families Deserve Truth From NIH Study on Psychiatric Drugs
- Sheets.Market Brings Professional Financial Model Templates to Entrepreneurs and Startups
- Scarecrow Fest offers fall-themed activities at Frankenmuth River Place Shops
- Webinar Announcement: Investing in the European Defense Sector—How the New Era of Uncertainty Is Redefining Investment Strategies
- AEVIGRA (AEIA) Analysis Reveals $350 Billion Counterfeit Market Driving Luxury Sector Toward Blockchain Authentication
- Town Center Family Dental Highlights Why Dental Implants No Longer Feel Forceful
- Her Magic Mushroom Memoir Launches as a Binge-Worthy Novel-to-Podcast Experience
- Century Fasteners de Mexico Hires Saúl Pedraza Gómez as Regional Sales Manager in Mexico
- Georgia Misses the Mark Again on Sports Betting, While Offshore Sites Cash In
- AAACF Annual Community Meeting Returns September 16: "Rising Together – Celebrating Our Collective Impact"
- $40 Price Target for $NRXP in H. C. Wainright Analyst Report on Leader in $3 Billion Suicidal Depression Market with Superior NRX 100 Drug Therapy
- Nashville International Chopin Piano Competition Partners with Crimson Global Academy to Support Excellence in Education
- AHRFD Releases Market Analysis: Cryptocurrency Market's Institutional Transformation Accelerating
- Ubleu Crypto Group Analyzes European Digital Asset Market Opportunities Amid Regulatory Evolution
- NIUFO Examines European MiCA Regulation's Impact on Digital Asset Trading Markets
- Wzzph Analyzes Crypto Market Maturation as Institutional Capital Drives $50B ETF Inflows